269 results on '"Chintagumpala, Murali M"'
Search Results
2. Children’s Oncology Group Trials in Retinoblastoma
3. Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children’s Oncology Group Study AREN0534
4. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
5. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
6. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma
7. Provider views on perioperative steroid use for patients with newly diagnosed pediatric brain tumors
8. ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis—A Report from the Children’s Oncology Group Study AREN0534
9. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma
10. Global health disparities in childhood cancers
11. Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling
12. Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study
13. Frequency and spectrum of clinically significant molecular alterations detected by tumor gene panel testing for pediatric cancer patients in the Texas KidsCanSeq study.
14. Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy
15. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors
16. Figure S2 from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
17. Table S2 from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
18. Data from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
19. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients
20. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321)
21. Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities
22. Outcomes of patients with bilateral retinoblastoma: A report from the RIVERBOAT Consortium.
23. Outcomes of patients with unilateral retinoblastoma: A report from the RIVERBOAT Consortium.
24. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Childrenʼs Oncology Group
25. Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)
26. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors
27. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors
28. Letter to the editor in response to Tang et al.
29. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma
30. Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic‐hypothalamic low‐grade glioma
31. ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
32. Early radiotherapy preserves vision in sporadic optic pathway glioma
33. Observed‐to‐expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis
34. Neonatal Retinoblastoma
35. A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group
36. Response criteria for intraocular retinoblastoma: RB‐RECIST
37. Global health disparities in childhood cancers
38. PATH-29. HIGH FREQUENCY OF CLINICALLY-RELEVANT TUMOR VARIANTS DETECTED BY MOLECULAR TESTING OF HIGH-RISK PEDIATRIC CNS TUMORS – PRELIMINARY FINDINGS FROM THE TEXAS KidsCanSeq STUDY
39. Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation
40. Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma
41. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group
42. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis
43. Global Disparities in Wilms Tumor
44. Neuropsychological Outcome Following Intensity-Modulated Radiation Therapy for Pediatric Medulloblastoma
45. Association Between Osteosarcoma and Deleterious Mutations in the RECQL4 Gene in Rothmund–Thomson Syndrome
46. Effect of intrapatient dosage escalation of irinotecan on its pharmacokinetics in pediatric patients who have high-grade gliomas and receive enzyme-inducing anticonvulsant therapy
47. Radiological Case of the Month
48. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma
49. Abstract 1575: DNA methylation-derived neutrophil-to-lymphocyte ratio and survival among pediatric medulloblastoma patients
50. Higher Rates of Pseudoprogression Among Pediatric Low-Grade Glioma Patients Treated with Proton versus Photon Radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.